Damora Therapeutics, Inc. has grown revenue 81% a year over three years and 65% a year over five. Revenue growth, 3-year annual rate: +81% (Biotechnology median +21%). Revenue growth, 5-year rate: +65%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

DMRADamora Therapeutics, Inc.

HealthcareUSD

$30.44

$2.5852 weeks$34.14

Is it growing?

Is DMRA growing?

Damora Therapeutics, Inc. has grown revenue 81% a year over three years and 65% a year over five.

+81%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +65%
Revenue growth, 5-year rate · +81% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›